David A. Sclar
Impact in
- Family Practice top 0.5%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Schizophrenia research and treatment 13
- Attention Deficit Hyperactivity Disorder 11
- Pharmacology 26
- Treatment of Major Depression 13
- Co-authors
- Tracy L. Skaer (66 shared papers)Linda M. Robison (60 shared papers)Richard S. Galin (18 shared papers)Alyssa M. Peckham (9 shared papers)Kathleen A. Fairman (15 shared papers)Jeffrey F. Barletta (2 shared papers)Mark P. Okamoto (10 shared papers)Phillip Lieberman (1 shared paper)
- Journals
- Clinical Therapeutics (6 papers)The Diabetes Educator (5 papers)PharmacoEconomics (4 papers)The Journal of Clinical Psychiatry (4 papers)The American Journal of Medicine (4 papers)
- Partner nations
- United StatesCanadaNew Zealand
In The Last Decade
David A. Sclar
125 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 149
- Family Practice 342
- Geriatrics and Gerontology 344
- Psychiatry and Mental health 878
- Pharmacology 492
- Applied Microbiology and Biotechnology 48
Countries citing papers authored by David A. Sclar
This map shows the geographic impact of David A. Sclar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Sclar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Sclar more than expected).
Fields of papers citing papers by David A. Sclar
This network shows the impact of papers produced by David A. Sclar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Sclar. The network helps show where David A. Sclar may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Sclar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 191 | |
| 2 | 2002 | 111 | |
| 3 | The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. | 1990 | 109 |
| 4 | Effect of health education in promoting prescription refill compliance among patients with hypertension. | 1991 | 97 |
| 5 | 2000 | 80 | |
| 6 | 1994 | 79 | |
| 7 | Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. | 1994 | 77 |
| 8 | 2010 | 72 | |
| 9 | 2018 | 71 | |
| 10 | 1995 | 71 | |
| 11 | 2013 | 70 | |
| 12 | 2017 | 69 | |
| 13 | 2017 | 69 | |
| 14 | 1993 | 67 | |
| 15 | 2014 | 62 | |
| 16 | 1996 | 53 | |
| 17 | 2009 | 52 | |
| 18 | 1999 | 49 | |
| 19 | 2002 | 47 | |
| 20 | Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. | 1993 | 46 |
About David A. Sclar
David A. Sclar is a scholar working on Psychiatry and Mental health, Pharmacology, Economics and Econometrics, Geriatrics and Gerontology and Public Health, Environmental and Occupational Health, having authored 135 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (22 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Medication Adherence and Compliance (13 papers), Schizophrenia research and treatment (13 papers), Treatment of Major Depression (13 papers), Mental Health Treatment and Access (11 papers), Attention Deficit Hyperactivity Disorder (11 papers) and Child and Adolescent Psychosocial and Emotional Development (10 papers). The work is most often cited by research in Family Practice (342 citations), Geriatrics and Gerontology (344 citations), Psychiatry and Mental health (878 citations), Pharmacology (492 citations) and Applied Microbiology and Biotechnology (48 citations). David A. Sclar has collaborated with scholars based in United States, Canada and New Zealand. Frequent co-authors include Tracy L. Skaer, Linda M. Robison, Richard S. Galin, Alyssa M. Peckham, Kathleen A. Fairman, Jeffrey F. Barletta, Mark P. Okamoto, Phillip Lieberman, Tommaso Tartaglione and Michael J. Fine. Their work appears in journals such as Clinical Therapeutics, The Diabetes Educator, PharmacoEconomics, The Journal of Clinical Psychiatry and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.